In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
Cleveland HeartLab
Quest Diagnostics Acquires Cleveland HeartLab to Establish Cardiometabolic COE
Quest Diagnostics has signed a definitive agreement to acquire Cleveland HeartLab, a provider of innovative diagnostic services for managing cardiovascular disease. A spin-off of Cleveland Clinic, Cleveland HeartLab has created a specialized approach to identifying risk of heart disease, based in part on science published in more than 100 peer reviewed journals. As part of the acquisition, Cleveland HeartLab will serve as the base for Quest's first national center of excellence in
Read More
